Search research articles
Contact Us
Filters
Showing results (231-240 of 259) with videos related to
Page
of 26
Sort By:
Diabetologia
|
August 8, 2025
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome
Alexandra J Roth-Schulze, Esther Bandala-Sanchez, Katrina M Ngui, et al.
Diabetologia
|
September 2, 2024
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study
Rebecca L Thomson, James D Brown, Helena Oakey, et al.
Diabetes Care
|
February 2, 2022
Mental Health During Late Pregnancy and Postpartum in Mothers With and Without Type 1 Diabetes: The ENDIA Study
Madeleine Hall, Helena Oakey, Megan A S Penno, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 8, 2021
Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic
Megan A S Penno, Amanda J Anderson, Rebecca L Thomson, et al.
Contemporary Clinical Trials
|
November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Anne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
The New England Journal of Medicine
|
December 6, 2023
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
Michaela Waibel, John M Wentworth, Michelle So, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 10, 2023
The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes
Christel Hendrieckx, Hanafi M Husin, Sienna Russell-Green, et al.
Diabetes Technology & Therapeutics
|
May 25, 2017
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend
Anneke Graf, Glenn M Ward, Sara Vogrin, et al.
Pediatric Diabetes
|
May 21, 2020
Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study
Megan A S Penno, Helena Oakey, Priya Augustine, et al.
Diabetes Technology & Therapeutics
|
November 12, 2016
Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study
Amin Sharifi, Martin I De Bock, Dilshani Jayawardene, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 259) with videos related to
Sort By:
Page
of 26
Diabetologia
|
August 8, 2025
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome
Alexandra J Roth-Schulze, Esther Bandala-Sanchez, Katrina M Ngui, et al.
Diabetologia
|
September 2, 2024
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study
Rebecca L Thomson, James D Brown, Helena Oakey, et al.
Diabetes Care
|
February 2, 2022
Mental Health During Late Pregnancy and Postpartum in Mothers With and Without Type 1 Diabetes: The ENDIA Study
Madeleine Hall, Helena Oakey, Megan A S Penno, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 8, 2021
Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic
Megan A S Penno, Amanda J Anderson, Rebecca L Thomson, et al.
Contemporary Clinical Trials
|
November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations
Anne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
The New England Journal of Medicine
|
December 6, 2023
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
Michaela Waibel, John M Wentworth, Michelle So, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 10, 2023
The diabetes management experiences questionnaire: Psychometric validation among adults with type 1 diabetes
Christel Hendrieckx, Hanafi M Husin, Sienna Russell-Green, et al.
Diabetes Technology & Therapeutics
|
May 25, 2017
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend
Anneke Graf, Glenn M Ward, Sara Vogrin, et al.
Pediatric Diabetes
|
May 21, 2020
Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study
Megan A S Penno, Helena Oakey, Priya Augustine, et al.
Diabetes Technology & Therapeutics
|
November 12, 2016
Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study
Amin Sharifi, Martin I De Bock, Dilshani Jayawardene, et al.
Page
of 26